{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12871118", "DateCompleted": {"Year": "2004", "Month": "03", "Day": "29"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "23"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0929-8673", "JournalIssue": {"Volume": "10", "Issue": "17", "PubDate": {"Year": "2003", "Month": "Sep"}}, "Title": "Current medicinal chemistry", "ISOAbbreviation": "Curr Med Chem"}, "ArticleTitle": "Combretastatin A-4 analogues as antimitotic antitumor agents.", "Pagination": {"StartPage": "1697", "EndPage": "1722", "MedlinePgn": "1697-722"}, "Abstract": {"AbstractText": ["Tubulin protein is a major target for anticancer drug discovery. As a result, antimitotic agents constitute an important class of the current anticancer drugs. Hundreds of tubulin inhibitors, naturally occurring, semisynthetic or synthetic, have been reported. Among these, combretastatin A-4 (CA-4), isolated from a South African tree Combretum caffrum, is one of the most potent antimitotic agents. CA-4 shows strong cytotoxicity against a variety of cancer cells, including multi-drug resistant cancer cell lines. It has also been demonstrated to exert highly selective effects in proliferating endothelial cells. CA-4 disodium phosphate (CA4DP), a water-soluble prodrug of CA-4, shows potent antivascular and antitumor effects in a wide variety of preclinical tumor models. Consequently, a number of CA-4 analogues has been synthesized and evaluated. In this paper, the structure-activity relationships and pharmacological properties of the CA-4 derivatives as a class of potent antimitotic anticancer agents are reviewed and discussed."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, College of Pharmacy, University of Rhode Island, RI 02881, USA. nhnam@hotmail.com"}], "Identifier": [], "LastName": "Nam", "ForeName": "Nguyen-Hai", "Initials": "NH"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Med Chem", "NlmUniqueID": "9440157", "ISSNLinking": "0929-8673"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Stilbenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin Modulators"}, {"RegistryNumber": "I5590ES2QZ", "NameOfSubstance": "fosbretabulin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["chemistry"], "DescriptorName": "Combretum"}, {"QualifierName": ["drug effects"], "DescriptorName": "Mitosis"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Stilbenes"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tubulin"}, {"QualifierName": [], "DescriptorName": "Tubulin Modulators"}], "NumberOfReferences": "143"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2003", "Month": "7", "Day": "23", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "3", "Day": "30", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "7", "Day": "23", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12871118", "10.2174/0929867033457151"]}}], "PubmedBookArticle": []}